NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
Key Information
Due Date: October 17, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Cooperative Agreement
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The objective of this funding is to back large-scale and complex research projects, which characterize multiple, highly integrated components, all centered on a common research question pertaining to AD/ADRD. These research initiatives are likely to be carried out by an integrated, multidisciplinary team of investigators. They could be based within a single institution or spread across a consortium of institutions.
The funded projects are expected to address one or more implementation research milestones related to AD/ADRD. By doing so, they should support the objectives of the National Plan to Address Alzheimer's and Related Dementias. It's important to note that the execution of a clinical trial is optional for this funding opportunity.
Key Dates
Open Date: December 22, 2021
Application Due Date: October 17, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses